Bure Equity AB
STO:BURE
Intrinsic Value
Bure Equity ABis an investment company with ownership interests in Nordic companies. [ Read More ]
The intrinsic value of one BURE stock under the Base Case scenario is 148.27 SEK. Compared to the current market price of 373.8 SEK, Bure Equity AB is Overvalued by 60%.
Valuation Backtest
Bure Equity AB
Run backtest to discover the historical profit from buying and selling BURE stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Bure Equity AB
Current Assets | 1.6B |
Cash & Short-Term Investments | 1.6B |
Receivables | 4m |
Non-Current Assets | 17.6B |
Long-Term Investments | 17.5B |
Intangibles | 33m |
Other Non-Current Assets | 46m |
Current Liabilities | 38m |
Other Current Liabilities | 38m |
Non-Current Liabilities | 33m |
Long-Term Debt | 1m |
Other Non-Current Liabilities | 32m |
Earnings Waterfall
Bure Equity AB
Revenue
|
202m
SEK
|
Cost of Revenue
|
-31m
SEK
|
Gross Profit
|
171m
SEK
|
Operating Expenses
|
-47m
SEK
|
Operating Income
|
124m
SEK
|
Other Expenses
|
4.6B
SEK
|
Net Income
|
4.7B
SEK
|
Free Cash Flow Analysis
Bure Equity AB
BURE Profitability Score
Profitability Due Diligence
Bure Equity AB's profitability score is 59/100. The higher the profitability score, the more profitable the company is.
Score
Bure Equity AB's profitability score is 59/100. The higher the profitability score, the more profitable the company is.
BURE Solvency Score
Solvency Due Diligence
Bure Equity AB's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Score
Bure Equity AB's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
BURE Price Targets Summary
Bure Equity AB
According to Wall Street analysts, the average 1-year price target for BURE is 83 SEK .
Shareholder Return
BURE Price
Bure Equity AB
Average Annual Return | 17.45% |
Standard Deviation of Annual Returns | 38.95% |
Max Drawdown | -64% |
Market Capitalization | 27.7B SEK |
Shares Outstanding | 74 146 896 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Bure Equity ABis an investment company with ownership interests in Nordic companies. The company is headquartered in Stockholm, Stockholm and currently employs 8 full-time employees. The firm specializes in long-term owning, developing, as well as disposing listed and unlisted operating entities. Its holding portfolio comprises eight firms: Cavotec, an engineering group that delivers power transmission, distribution and control technologies to a range of areas; MedCap, which owns and develops companies involved in the Life Science sector; Mycronic, which designs and manufactures laser-based pattern generators that are used in the flexible electronics production; PartnerTech, providing product development, as well as production, logistics and aftermarket services; Vitrolife, a developer and producer of solutions for fertility treatment; XVIVO Perfusion AB, which focuses on organ, tissue and cell preservation in relation with transplantation; Investment AB Bure, which owns and manages leasing of locomotives; and Mercuri International, which offers sales and management training consultancy.
Contact
IPO
Employees
Officers
The intrinsic value of one BURE stock under the Base Case scenario is 148.27 SEK.
Compared to the current market price of 373.8 SEK, Bure Equity AB is Overvalued by 60%.